Delivery Order SPE2DB22D1017-SPE2DB25FG8CH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.35 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $2,091.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,956.40 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Advair HFA 230-21 micrograms inhalers (12-gram units). This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gram units) with a ceiling value of $9,743.54. This competitive award, with a firm fixed price structure and no set-aside designation, is scheduled for completion by July 21, 2025. The contract represents a continuation of the company's pharmaceutical supply services under its existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $6,621.48 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for Advair HFA 230-21 mcg inhaler 12 gram units. This is a firm fixed price, non-competitive set-aside contract with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader contractual relationship...
- The Defense Logistics Agency (DLA) awarded a $1,900.89 delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhaler (12 grams) under a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of July 23, 2025, one day after the award date of July 22, 2025. Performance will take place at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued against...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,549.84 to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the provision of Advair HFA 230-21 MCG Inhaler 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhalers (12 grams) under a firm fixed price contract with a ceiling value of $6,339.94. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, serving the Defense...
- The Defense Logistics Agency awarded a $2,513.37 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12 grams) with a completion date of July 22, 2025. This non-set-aside contract represents a firm fixed price delivery order under a competitive procurement process. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical supply chains, particularly for military and...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8CHDelivery Order
The Defense Logistics Agency awarded a $2,416.18 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 grams). The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award through open procurement. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's comprehensive IDC vehicle enables supply of a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. This specific delivery order for respiratory medication exemplifies the company's role in providing essential brand-name pharmaceutical products through DLA's medical supply chain to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/24/25 |